Industry Updates
This broad category includes articles concerning health insurance costs, carrier and health plan news, changing benefits technology, and surveys by the Kaiser Family Foundation and others on employee benefits.
Nevada will save money when it ditches the federally run HealthCare.gov enrollment system in 2019 for a state-based website, state health officials said.
After spending most of 2017 defending the Affordable Care Act from GOP attacks, a growing number of Democrats believe the law's reliance on private insurance markets won't be enough and the party should focus instead on expanding popular government programs like Medicare and Medicaid.
The role of the health insurance broker is reinforced daily by their clients, members of the National Association of Health Underwriters (NAHU) were told at the opening of their 2018 Capitol Conference today.
A new study indicates that almost 29 million Americans lack health insurance — a big improvement compared to nearly 49 million in 2010.
Seniors in wellness programs targeting obesity, falling and chronic conditions are not sparking healthcare spending decreases, according to a federal analysis released Friday.
Early this month, advocates of moving California to a single-payer health care system renewed their push in Sacramento. Hundreds of them crowded into a hearing of a special state Assembly committee that's exploring whether and how to bring universal health care to the state.
Rick, Patrick and Michael recently commented on Covered California’s Facebook page, urging others to ditch health insurance.
Insurers will again be able to sell short-term health insurance good for up to 12 months under a proposed rule released Tuesday by the Trump administration that could further roil the marketplace.
By many measures, the rambunctious campaign for a single-payer health care system in California appears to be floundering.
Food and Drug Administration Commissioner Scott Gottlieb said he will do everything “within my lane” to combat high drug prices and that he sees drug companies “gaming the system to try to block competition” in a multitude of ways in the marketplace.